Expansion in scid mice of Epstein–Barr virus-associated post-transplantation lymphoproliferative disease biopsy material

References

1. Armitage J. M., Kormos R. L., Stuart R. S., Fricker F. J., Griffith B. P., Nalesnik M., Hardesty R. L., Dummer J. S. 1991; Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. Journal of Heart and Lung Transplantation 10:877–886
   [Google Scholar]
2. Bosma G. C., Custer R. P., Bosma M. J. 1983; A severe combined immunodeficiency mutation in the mouse. Nature 301:527–530
   [Google Scholar]
3. Cen H., Williams P. A., McWilliams H. P., Breinig M. C., Ho M., McKnight J. L. C. 1993; Evidence for restricted Epstein–Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders. Blood 81:1393–1403
   [Google Scholar]
4. Crawford D. H. 2001; Biology and disease associations of Epstein–Barr virus. Philosophical Transactions of the Royal Society of London B Biological Sciences 356:461–473
   [Google Scholar]
5. Deacon E. M., Pallesen G., Niedobitek G., Crocker J., Brooks L., Rickinson A. B., Young L. S. 1993; Epstein–Barr virus and Hodgkin′s disease: transcriptional analysis of virus latency in the malignant cells. Journal of Experimental Medicine 177:339–349
   [Google Scholar]
6. Gardella T., Medveczky P., Sairenji T., Mulder C. 1984; Detection of circular and linear herpesvirus DNA molecules in mammalian cells by electrophoresis. Journal of Virology 50:248–254
   [Google Scholar]
7. Ho M., Miller G., Atchison R. W., Breinig M. K., Dummer J. S., Andiman W., Starzl T. E., Eastman R., Griffith B. P., Hardesty R. L. 1985; Epstein–Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. Journal of Infectious Diseases 152:876–886
   [Google Scholar]
8. Howe J. G., Steitz J. A. 1986; Localization of Epstein–Barr virus-encoded small RNAs by in situ hybridization. Proceedings of the National Academy of Sciences, USA 83:9006–9010
   [Google Scholar]
9. Hurley E. A., Thorley-Lawson D. A. 1988; B cell activation and the establishment of Epstein–Barr virus latency. Journal of Experimental Medicine 168:2059–2075
   [Google Scholar]
10. Itoh T., Shiota M., Takanashi M., Hojo I., Satoh H., Matsuzawa A., Moriyama T., Watanabe T., Hirai K., Mori S. 1993; Engraftment of human non-Hodgkin lymphomas in mice with severe combined immunodeficiency. Cancer 72:2686–2694
    [Google Scholar]
11. Johannessen I., Crawford D. H. 1999; In vivo models for Epstein–Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD. Reviews in Medical Virology 9:263–277
    [Google Scholar]
12. Johannessen I., Asghar M., Crawford D. H. 2000; Essential role for T cells in human B cell lymphoproliferative disease development in SCID mice. British Journal of Haematology 109:600–610
    [Google Scholar]
13. Kuppers R., Hansmann M.-L., Rajewsky K. 1995; Micromanipulation and PCR analysis of single cells from tissue sections. In Handbook of Experimental Immunology pp. 206, 1–4 Edited by Weir D. M., Blackwell C., Herzenberg L. A. Cambridge, MA: Blackwell Scientific;
    [Google Scholar]
14. McCarthy K., Sloane J., Wiedermann L. 1990; Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens. Journal of Clinical Pathology 43:429–432
    [Google Scholar]
15. Meggetto F., Muller C., Henry S., Selves J., Mariame B., Brousset P., Saati T. A., Delsol G. 1996; Epstein–Barr virus (EBV)-associated lymphoproliferations in severe combined immunodeficient mice transplanted with Hodgkin′s disease lymph nodes: implication of EBV+ve bystander B lymphocytes rather than EBV-infected Reed–Sternberg cells. Blood 87:2435–2442
    [Google Scholar]
16. Opelz G., Henderson R. 1993; Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342:1514–1516
    [Google Scholar]
17. Oudejans J. J., Jiwa M., van den Brule A. J., Grasser F. A., Horstman A., Vos W., Kluin P. M., van der Valk P., Walboomers J. M., Meijer C. J. 1995; Detection of heterogeneous Epstein–Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders. American Journal of Pathology 147:923–933
    [Google Scholar]
18. Perera S. M., Johannessen I., Thomas J. A., Brooks L. A., Jobe J. N., Crawford D. H., Radley-Smith R., Phillips M. 1996; Growth of Epstein–Barr virus-associated B-lymphoproliferative disease tissue in a severe combined immunodeficient mouse. Blood 88:1123–1125
    [Google Scholar]
19. Perera S. M., Thomas J. A., Burke M., Crawford D. H. 1998; Analysis of the T-cell micro-environment in Epstein–Barr virus-related post-transplantation B lymphoproliferative disease. Journal of Pathology 184:177–184
    [Google Scholar]
20. Raab-Traub N., Flynn K. 1986; The structure of the termini of the Epstein–Barr virus as a marker of clonal cellular proliferation. Cell 47:883–889
    [Google Scholar]
21. Randhawa P. S., Pietrzak B., Nalesnik M. A., Demetris A. J., Locker J. 1997; Subcutaneous implantation of human post-transplant lymphoproliferative disease lesions in scid mice. Hematological Oncology 15:39–46
    [Google Scholar]
22. Reedman B. M., Klein G. 1973; Cellular localization of an Epstein–Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. International Journal of Cancer 11:499–520
    [Google Scholar]
23. Rubini J. R., Cronkite E. P., Bond V. P., Fliedner T. M. 1960; The metabolism and fate of tritiated thymidine in man. Journal of Clinical Investigation 39:909–918
    [Google Scholar]
24. Stetler-Stevenson M., Crush-Stanton S., Cossman J. 1990; Involvement of the bcl-2 gene in Hodgkin′s disease. Journal of the National Cancer Institute 82:855–858
    [Google Scholar]
25. Taylor J. H., Woods P. S., Hughes W. L. 1957; The organization and duplication of chromosomes as revealed by autoradiographic studies using tritium-labeled thymidine. Proceedings of the National Academy of Sciences, USA 43:122–128
    [Google Scholar]
26. Thomas J. A., Hotchin N. A., Allday M. J., Amlot P., Rose M., Yacoub M., Crawford D. H. 1990; Immunohistology of Epstein–Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation 49:944–953
    [Google Scholar]
27. Van Noorden S. 1986; Tissue preparation and immunostaining techniques for light microscopy. In Immunocytochemistry: Modern Methods and Applications pp 26–53 Edited by Polak J. M., Van Noorden S. Bristol: Wright;
    [Google Scholar]
28. Yamamura M., Uyemura K., Deans R. J., Weinberg K., Rea T. H., Bloom B. R., Modlin R. L. 1991; Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277–279
    [Google Scholar]
29. Yamamura M., Wang X. H., Ohmen J. D., Uyemura K., Rea T. H., Bloom B. R., Modlin R. L. 1992; Cytokine patterns of immunologically mediated tissue damage. Journal of Immunology 149:1470–1475
    [Google Scholar]